Clinical Evaluation of Two Approved Contact Lenses

Exclusion Criteria

• •1. Currently pregnant or breastfeeding (subjects who become pregnant during the study will be discontinued).
• •2. Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
• •3. Any autoimmune disease or use of medication, which may interfere with contact lens wear.
• •4. Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, or aphakia.
• •5. Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.).
• •6. Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.
• •7. Any ocular infection.
• •8. Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
• •9. Monovision, multi-focal, toric, or extended wear contact lens correction.
• •10. Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.
• •11. History of binocular vision abnormality or strabismus that is likely to affect successful contact lens wear.
• •12. Any infectious disease (e.g., hepatitis, tuberculosis) or contagious immunosuppressive diseases (e.g., HIV) by self-report.